Authors: Munazza Ehsan, Muhammad Aslam Rind, Maria Nazir, Muhammad Saleem Rind
Abstract
Frequency of adverse effects of interferon treatment in Hepatitis C Patients. Study design: Cross sectional descriptive study. Period: Six months setting: Departments of Medicine, Liaquat University of Medical and Health Sciences Jamshoro/ Hyderabad. Material & Methods: 280 patients of hepatitis C undergoing treatment with alpha Interferon were included in the study. Continuous variables such as age, duration of disease, duration of Interferon, were computed as (Mean ± Standard Deviation). Categorical variables such as patient sex,adverse effects such as anemia, neutropenia, thrombocytopenia, hyperthyroidism, hypothyroidism after therapy was presented as frequency and percentage. Post-stratification chi- square test was applied. P<0.05 was taken as significant. The SPSS software version 20 was used for data analysis and evaluations. Results: In our study of 280 patients, the gender distributions was assessed; male 118 (42.1%) and females 162 (57.9%). The mean duration of Interferon treatment was 4.4 months. Hematological adverse effects were assessed and 91(32.5%) patients had neutropenia and 189(67.5%) had normal neutrophil count. The mean level of hemoglobin was 10.3mg/dl, minimum hemoglobin level was 5.00 mg/dl and maximum level was 14.00 mg/dl. Thrombocytopenia was found in 122(43.6%) of patients as per diagnostic criteria. 21 (7.5%) of patients had developed hyperthyroidism. Body Mass Index of the patients were evaluated. Mean BMI of study population was 26.05 Kg/m2 with Std. deviation of 5.6378 Kg/m2 . Minimum BMI was 15Kg/m2 and maximum BMI was 40 Kg/m2 Conclusion: The frequency of adverse effects of Interferon therapy in patients of hepatitis C is an important aspect to be considered. This study suggests that hematological adverse effects are common with Interferon therapy in patients of Hepatitis C.
Keywords: Interferon therapy, hepatitis C, anemia, thrombocytopenia.
